Welcure Drugs and Pharmaceuticals Limited (BOM:524661)
India · Delayed Price · Currency is INR 0.2400
0.00 (0.00%)
At close: Jul 28, 2026
BOM:524661 Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 5.76 | 1.28 | 0.22 | 0.01 | 0.66 |
Cash & Short-Term Investments | 5.76 | 1.28 | 0.22 | 0.01 | 0.66 |
Cash Growth | 349.10% | 493.98% | 1700.00% | -98.18% | 39.09% |
Accounts Receivable | 2,134 | 189.5 | - | - | - |
Receivables | 2,134 | 189.5 | - | - | - |
Inventory | 1,435 | 1,435 | - | - | - |
Other Current Assets | 0.9 | 195.39 | 0.1 | 0.05 | - |
Total Current Assets | 3,575 | 1,821 | 0.32 | 0.06 | 0.66 |
Property, Plant & Equipment | 0.11 | 0.3 | 0.21 | 0.57 | - |
Long-Term Investments | 12.87 | - | - | 1.65 | - |
Other Long-Term Assets | 0.8 | 0.77 | 0.31 | 0.31 | 0.31 |
Total Assets | 5,102 | 2,670 | 13.71 | 15.29 | 0.97 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 1,995 | 28.98 | - | - | - |
Accrued Expenses | - | 0.61 | 0.11 | 0.14 | 0.04 |
Current Income Taxes Payable | - | 6.1 | - | - | - |
Other Current Liabilities | 2,137 | 377 | 0.2 | - | - |
Total Current Liabilities | 4,132 | 412.69 | 0.31 | 0.14 | 0.04 |
Long-Term Debt | - | 1,232 | - | - | - |
Other Long-Term Liabilities | 0 | - | -0 | 0 | - |
Total Liabilities | 4,132 | 1,645 | 0.31 | 0.14 | 0.04 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 1,236 | 1,124 | 134.39 | 134.39 | 121.19 |
Retained Earnings | -265.74 | -99.29 | -120.99 | -119.24 | -120.26 |
Comprehensive Income & Other | - | - | - | -0 | - |
Shareholders' Equity | 970.2 | 1,025 | 13.41 | 15.15 | 0.93 |
Total Liabilities & Equity | 5,102 | 2,670 | 13.71 | 15.29 | 0.97 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | - | 1,232 | - | - | - |
Net Cash (Debt) | 5.76 | -1,231 | 0.22 | 0.01 | 0.66 |
Net Cash Growth | - | - | 1700.00% | -98.18% | 39.09% |
Net Cash Per Share | 0.00 | -1.43 | 0.00 | 0.00 | 0.00 |
Filing Date Shares Outstanding | 1,236 | 1,238 | 148.63 | 148.63 | 148.63 |
Total Common Shares Outstanding | 1,236 | 1,238 | 148.63 | 148.63 | 148.63 |
Working Capital | -556.2 | 1,409 | 0.01 | -0.08 | 0.62 |
Book Value Per Share | 0.78 | 0.83 | 0.09 | 0.10 | 0.01 |
Tangible Book Value | 970.2 | 1,025 | 13.41 | 15.15 | 0.93 |
Tangible Book Value Per Share | 0.78 | 0.83 | 0.09 | 0.10 | 0.01 |
Machinery | - | 0.77 | 0.6 | - | - |